ArticleCureus2025
When the Numbers Lie: Uncovering Pseudohyponatremia After an Anabolic Steroid Injection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudohyponatremia is a laboratory artifact in which serum sodium levels appear falsely low despite normal serum osmolality. It typically occurs in the presence of hypertriglyceridemia or paraproteinemia, but this case highlights a rare etiology: inadvertent intravenous injection of an oil-diluted anabolic steroid. A 42-year-old healthy man presented to the emergency department with nausea, vomiting, and presyncope. He reported injecting trenbolone intramuscularly three days prior and noted blood aspiration before injection, suggesting possible intravenous administration. He denied other recent illnesses or exposures. On examination, he was afebrile, hemodynamically stable, and non-toxic, with an unremarkable physical exam. Initial laboratory results revealed a serum sodium level of 125 mmol/L. However, the measured serum osmolality was 289 mOsm/kg while the calculated osmolality was 259 mOsm/kg, revealing an osmolal gap. A point-of-care iSTAT revealed a sodium level of 137 mmol/L, indicating true normonatremia and supporting the diagnosis of pseudohyponatremia. Additional labs showed erythrocytosis, consistent with anabolic steroid use, and no evidence of hypertriglyceridemia or paraproteinemia. Nephrology was consulted due to concern for symptomatic hyponatremia. With a normal measured osmolality, normal lipid and protein levels, and a history of recent anabolic steroid injection, the low serum sodium level was attributed to a laboratory artifact resulting from nonaqueous solvent interference. The patient was admitted for observation and remained stable, with improving symptoms and normalizing labs. Serum sodium by main-lab indirect analysis was 136 mmol/L by the time of discharge on hospital day two. He was discharged with outpatient follow-up. In patients with unexplained hyponatremia and normal clinical status, pseudohyponatremia must be considered. Prompt recognition can prevent unnecessary treatments, reduce patient risk, and guide appropriate care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.